PharmaEssentia Corporation
6446
Rankning i aktier
#1413
PharmaEssentia Corporation is a biopharmaceutical firm dedicated to developing... PharmaEssentia Corporation is a biopharmaceutical firm dedicated to developing therapies for human ailments, serving both the Taiwanese and international markets. Its product portfolio prominently features Ropeginterferon alfa-2b, indicated for the management of various hematological conditions including chronic myelogenous leukemia, T-Cell leukemia, early myelofibrosis, polycythemia vera, and essential thrombocythemia. Beyond this, the company's pipeline includes TCRT, anti PD-1, PEG-cytokine X,Y, and novel checkpoint antibodies, all under development for solid tumors. A specific combination, P1101 + anti PD-1, is being explored for hepatocellular carcinoma, while PEG-GCSF addresses neutropenia. Fundamentally, its comprehensive research and development initiatives span key therapeutic areas such as hematology, infectious diseases, and oncology. Established in 1990, PharmaEssentia Corporation maintains its headquarters in Taipei, Taiwan.
Aktiekurs
$37.84
Marknadsvärde
$15.65B
Förändring (1 dag)
3.03%
Förändring (1 år)
148.76%
Land
TW
Handel PharmaEssentia Corporation (6446)
Kategori
Healthcare
P/B-tal för PharmaEssentia Corporation (6446)
P/B-tal per October 2026 TTM: 13.50
Enligt PharmaEssentia Corporation senaste finansiella rapporter och aktiekurs är det aktuella P/B-talet (TTM) 13.50. I slutet av 2023 hade företaget ett P/B-tal på 4.70.
Historik för P/B-tal för PharmaEssentia Corporation från 2010 till 2026
P/B-tal vid årets slut
| År | P/B-tal | Ändra |
|---|---|---|
| 2026 (TTM) | 13.50 | 85.23% |
| 2024 | 7.29 | 54.92% |
| 2023 | 4.70 | -57.85% |
| 2022 | 11.16 | -36.95% |
| 2021 | 17.70 | 205.50% |
| 2020 | 5.79 | -44.22% |
| 2019 | 10.39 | -30.22% |
| 2018 | 14.88 | 65.96% |
| 2017 | 8.97 | 16.17% |
| 2016 | 7.72 | -85.09% |
| 2015 | 51.79 | 198.70% |
| 2014 | 17.34 | 0.82% |
| 2013 | 17.20 | -64.44% |
| 2012 | 48.36 | -92.11% |
| 2011 | 613.14 | 490.71% |
| 2010 | 103.80 | 0.00% |
P/B-tal för liknande företag eller konkurrenter
| Företag | P/B-tal | Skillnad i P/B-tal | Land |
|---|---|---|---|
| - | - |
DE
|
|
| - | - |
DE
|
|
| - | - |
JP
|
|
| - | - |
CH
|
|
| 5.041 | -62.67% |
IN
|
